From DNA-Encoded Chemistry to Tumor-Targeted Small Molecule Therapeutics
Pharmaceuticals · 23.07.2026 · 19 (8) · 1137
DOI: 10.3390/ph19081137 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 23.07.2026. Verfasst von Samuele Cazzamalli und 1 weiteren Autor:innen. Beteiligte Einrichtung: R&D Department, Philochem AG, CH-8112 Otelfingen, Switzerland. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Philochem AG.
Abstract (Originalsprache)
Unlike conventional screening methods, which are limited by library size, DNA-encoded chemical library (DEL) technology enables the simultaneous interrogation of billions of compounds, each uniquely barcoded with DNA tags. These libraries can be screened through affinity-based capture and decoded using high-throughput sequencing. DEL-derived ligands can be conjugated to cytotoxic agents or radioactive isotopes, facilitating the creation of highly selective therapeutics that target diseased cells while minimizing off-target effects. This article explores the use of DELs for identifying high-affinity small organic ligands for the development of small molecule–radio conjugates (SMRCs) and small molecule–drug conjugates (SMDCs).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- R&D Department, Philochem AG, CH-8112 Otelfingen, Switzerland.
- Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology, CH-8093 Zurich, Switzerland.
- Philogen S.p.A., 53100 Siena, Italy.
Förderung
- Philochem AG
Zitieren
APA
Cazzamalli, S., & Neri, D. (2026). From DNA-Encoded Chemistry to Tumor-Targeted Small Molecule Therapeutics. Pharmaceuticals, 19(8), 1137. https://doi.org/10.3390/ph19081137
Vancouver
Cazzamalli S, Neri D. From DNA-Encoded Chemistry to Tumor-Targeted Small Molecule Therapeutics. Pharmaceuticals. 2026;19(8):1137. doi:10.3390/ph19081137
BibTeX
@article{Cazzamalli2026,
author = {Cazzamalli, Samuele and Neri, Dario},
title = {From DNA-Encoded Chemistry to Tumor-Targeted Small Molecule Therapeutics},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {8},
pages = {1137},
doi = {10.3390/ph19081137}
}
EUVIMED